Stockreport

RegeneRx advancing pipeline candidates [Seeking Alpha]

REGENERX BIOPHARMS INC  (RGRX) 
NASDAQ:AMEX Investor Relations: regenerx.com/investors
PDF In an update for investors, RegeneRx Biopharmaceuticals ( OTCQB:RGRX ) announces its progress on two pipeline candidates. RGN-259: A Phase 3 clinical trial, A [Read more]